Mousa O. Germoush

2.4k total citations
69 papers, 1.7k citations indexed

About

Mousa O. Germoush is a scholar working on Molecular Biology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Mousa O. Germoush has authored 69 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Pharmacology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Mousa O. Germoush's work include Drug-Induced Hepatotoxicity and Protection (12 papers), Chemotherapy-induced organ toxicity mitigation (9 papers) and Synthesis and biological activity (6 papers). Mousa O. Germoush is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (12 papers), Chemotherapy-induced organ toxicity mitigation (9 papers) and Synthesis and biological activity (6 papers). Mousa O. Germoush collaborates with scholars based in Saudi Arabia, Egypt and South Korea. Mousa O. Germoush's co-authors include Ayman M. Mahmoud, Omnia E. Hussein, May Bin‐Jumah, Mohammed Alotaibi, Mohammad H. Abukhalil, Hassan A. Elgebaly, Mohamed M. Abdel‐Daim, Md. Habibur Rahman, Amir M. Al Hroob and Osama Y. Althunibat and has published in prestigious journals such as Scientific Reports, Molecules and Life Sciences.

In The Last Decade

Mousa O. Germoush

64 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mousa O. Germoush Saudi Arabia 23 464 317 289 216 168 69 1.7k
Walaa G. Hozayen Egypt 22 514 1.1× 397 1.3× 330 1.1× 182 0.8× 121 0.7× 57 1.6k
Akram Jamshidzadeh Iran 31 392 0.8× 485 1.5× 187 0.6× 204 0.9× 147 0.9× 119 2.4k
Abdul Lateef India 22 556 1.2× 390 1.2× 325 1.1× 249 1.2× 183 1.1× 50 1.7k
Esrafil Mansouri Iran 26 522 1.1× 224 0.7× 234 0.8× 252 1.2× 127 0.8× 92 1.8k
El‐Shaimaa A. Arafa Egypt 25 789 1.7× 275 0.9× 303 1.0× 261 1.2× 156 0.9× 63 2.1k
Krishnendu Sinha India 17 903 1.9× 221 0.7× 212 0.7× 199 0.9× 153 0.9× 28 2.4k
Mehdi Goudarzi Iran 27 372 0.8× 375 1.2× 378 1.3× 354 1.6× 189 1.1× 94 1.8k
Osman Çiftçi Türkiye 27 412 0.9× 235 0.7× 406 1.4× 333 1.5× 223 1.3× 108 2.1k
Tayyaba Afsar Saudi Arabia 22 364 0.8× 135 0.4× 272 0.9× 226 1.0× 100 0.6× 105 1.6k
Suhail Razak Saudi Arabia 24 404 0.9× 132 0.4× 292 1.0× 276 1.3× 106 0.6× 134 1.9k

Countries citing papers authored by Mousa O. Germoush

Since Specialization
Citations

This map shows the geographic impact of Mousa O. Germoush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mousa O. Germoush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mousa O. Germoush more than expected).

Fields of papers citing papers by Mousa O. Germoush

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mousa O. Germoush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mousa O. Germoush. The network helps show where Mousa O. Germoush may publish in the future.

Co-authorship network of co-authors of Mousa O. Germoush

This figure shows the co-authorship network connecting the top 25 collaborators of Mousa O. Germoush. A scholar is included among the top collaborators of Mousa O. Germoush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mousa O. Germoush. Mousa O. Germoush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
6.
Alrashdi, Barakat M., et al.. (2025). Cardioprotective, anti-inflammatory, and antioxidative outcome of costus against bleomycin-induced cardiotoxicity in rat model. Journal of Genetic Engineering and Biotechnology. 23(1). 100466–100466. 5 indexed citations
8.
Alruhaimi, Reem S., Ahmad Ahmeda, Omnia E. Hussein, et al.. (2024). Galangin attenuates chlorpyrifos-induced kidney injury by mitigating oxidative stress and inflammation and upregulating Nrf2 and farnesoid-X-receptor in rats. Environmental Toxicology and Pharmacology. 110. 104542–104542. 4 indexed citations
9.
Massoud, Diaa, et al.. (2024). Exploration the Effects of Mesenchymal Stem Cells and Olive Leaf Extract on Physiological and Histopathological Changes on the Kidney of Diabetes Rats. Cellular Physiology and Biochemistry. 58(6). 807–822. 1 indexed citations
10.
Alrashdi, Barakat M., et al.. (2024). <b>Evaluation of the anti-diabetic and anti-inflammatory potentials of curcumin nanoparticle in diabetic rat induced by streptozotocin</b>. Open Veterinary Journal. 14(12). 3375–3375. 2 indexed citations
11.
Khan, Mohsin Abbas, Irshad Ahmad, Umair Khurshid, et al.. (2023). A Comprehensive Approach to Derivatization: Elemental Composition, Biochemical, and In Silico Studies of Metformin Derivatives Containing Copper and Zinc Complexes. Molecules. 28(3). 1406–1406. 1 indexed citations
12.
Elshanbary, Alaa Ahmed, Anas Zakarya Nourelden, Khaled Mohamed Ragab, et al.. (2022). The diagnostic accuracy of intraoperative frozen section biopsy for diagnosis of sentinel lymph node metastasis in breast cancer patients: a meta-analysis. Environmental Science and Pollution Research. 29(32). 47931–47941. 12 indexed citations
13.
Kara, Mohammed, Amine Assouguem, Arwa Abdulkreem AL‐Huqail, et al.. (2022). Isolation and Characterization of Three New Crude Oil Degrading Yeast Strains, Candida parapsilosis SK1, Rhodotorula mucilaginosa SK2 and SK3. Sustainability. 14(6). 3465–3465. 13 indexed citations
14.
Tagde, Priti, Priti Tagde, Pooja Tagde, et al.. (2021). The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders. Molecules. 26(23). 7109–7109. 115 indexed citations
15.
Althunibat, Osama Y., Amir M. Al Hroob, Mohammad H. Abukhalil, et al.. (2019). Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy. Life Sciences. 221. 83–92. 122 indexed citations
16.
Mahmoud, Ayman M., Ayman M. Mahmoud, Mousa O. Germoush, et al.. (2018). Commiphora molmol protects against methotrexate-induced nephrotoxicity by up-regulating Nrf2/ARE/HO-1 signaling. Biomedicine & Pharmacotherapy. 106. 499–509. 73 indexed citations
17.
Germoush, Mousa O.. (2016). Antioxidant and anti-inflammatory effects of Padina pavonia and Turbenaria ornate in streptozotocin/ nicotinamide diabetic rats. 3 indexed citations
18.
Mahmoud, Ayman M., Omnia E. Hussein, & Mousa O. Germoush. (2016). Ruta graveolens Protects Against Isoniazid/Rifampicin-Induced Nephrotoxicity through Modulation of Oxidative Stress and Inflammation. 2(1). 8–13. 9 indexed citations
19.
Germoush, Mousa O. & Ayman M. Mahmoud. (2014). Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines. Journal of Cancer Research and Clinical Oncology. 140(7). 1103–1109. 97 indexed citations
20.
Mohamed, Ashraf M., et al.. (2013). Anticancer activities of some newly synthesized pyrazole and pyrimidine derivatives. Archives of Pharmacal Research. 36(9). 1055–1065. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026